Testing version — LOERadar is in active testing. Features and data may change.
ALLI (ORLISTAT) | LOERadar
ALLI
NDA
ORLISTAT | N021887 | HALEON US HOLDINGS LLC
1 strength0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 60MG
RLD
0 patents0 exclusivities▴
CAPSULE;ORAL | Approved: Feb 7, 2007
No patent or exclusivity listings for this strength.